National trends and demographic disparities in mortality involving co-listed chronic obstructive pulmonary disease and substance use disorders among U.S. adults aged ≥65 years: A population-based serial cross-sectional CDC WONDER analysis, 1999 to 2020
14 affiliations
- 1Department of Medicine, Rahbar Medical & Dental College, Lahore, Pakistan
- 2Department of Medicine, FMH College of Medicine & Dentistry, Lahore, Pakistan
- 3Department of Medicine, Punjab Medical College, Faisalabad, Pakistan
- 4Department of Medicine, Islam Medical and Dental College, Sialkot, Pakistan
- 5Department of Medicine, Rashid Latif Medical College, Lahore, Pakistan
- 6Department of Medicine, Akhtar Saeed Medical & Dental College, Lahore, Pakistan
- 7Department of Medicine, Lahore Medical & Dental College, Lahore, Pakistan
- 8Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan
- 9Department of Internal Medicine, Nepalgunj Medical College, Nepalgunj, Nepal
- 10Department of Medicine, Ziauddin Medical College, Karachi, Pakistan
- 11Department of Medicine, Shalamar Medical and Dental College, Lahore, Pakistan
- 12Department of Medicine, Dow International Medical College, Karachi, Pakistan
- 13Faculty of Medicine and Surgery, Salaam University, Mogadishu, Somalia
- 14Faculty of Medicine and Health Science, Somali National University, Mogadishu, Somalia.
Abstract
Chronic obstructive pulmonary disease (COPD) and substance use disorders (SUDs) frequently coexist, yet national mortality patterns involving both conditions among older adults remain incompletely characterized. We evaluated temporal, demographic, geographic, and substance-specific patterns in U.S. death records co-listing COPD and SUDs among adults aged ≥65 years. We conducted a descriptive serial cross-sectional analysis of Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research multiple cause of death data from 1999 to 2020. Eligible records included deaths among adults aged ≥65 years in which COPD (International Classification of Diseases, 10th revision J41–J44) and SUDs (F10–F19) were both recorded in the Multiple Cause of Death fields. Age-adjusted mortality rates (AAMRs) were calculated overall and by sex, race/ethnicity, census region, urbanization, and state; age-group analyses used age-specific crude mortality rates. Joinpoint regression estimated annual percent changes and average annual percent changes. Secondary analyses examined individual F10 to F19 categories, with a sensitivity analysis excluding tobacco/nicotine-related disorders (F17). Among 1,524,216 qualifying deaths, the overall AAMR increased from 25.5/100,000 in 1999 to 213.2 in 2020, peaking at 219.0 in 2017. Males had higher pooled AAMRs than females (216.98 vs 132.54). The highest pooled racial/ethnic AAMR occurred among non-Hispanic American Indian or Alaska Native adults (191.99), followed closely by non-Hispanic White adults (188.68). The Midwest had the highest regional AAMR, while nonmetropolitan counties had higher AAMRs than metropolitan counties (232.82 vs 152.03). Tobacco/nicotine-related disorders accounted for the predominant substance-specific burden. Excluding F17 yielded an average annual percent change of 2.19% (95% confidence interval, 1.37–3.02). In the overall F10 to F19 analysis, mortality involving co-listed COPD and SUDs increased markedly during the earlier study period before stabilizing, whereas temporal trajectories differed across individual substance categories. Substantial demographic, geographic, and substance-specific heterogeneity was observed. Findings are descriptive and should not be interpreted causally.
Related
- Temporal trends and disparities in mortality involving chronic kidney disease and malnutrition among U.S. adults, 1999–2024: a nationwide population-based study
- Racial, sex, and geographic disparities in mortality involving stroke and chronic kidney disease: a CDC WONDER database analysis, 1999–2020
- National trends and disparities in mortality involving bladder cancer and substance use disorders in the United States, 1999–2023
- National trends, demographic disparities, and phenotypic shifts in encephalopathy-associated mortality in the United States: A CDC WONDER analysis, 1999-2024
- Demographic and geographic disparities in mortality among U.S. adults with osteomyelitis: a CDC WONDER analysis, 1999-2023.
BibTeX
@article{arshad2026national,
title = {{National trends and demographic disparities in mortality involving co-listed chronic obstructive pulmonary disease and substance use disorders among U.S. adults aged ≥65 years: A population-based serial cross-sectional CDC WONDER analysis, 1999 to 2020}},
author = {Mirza Ammar Arshad and Urwah Noor and Rida Fatima and Fatima Maqsood and Hassan Faraz Chaudhry and Muhammad Shumas and Amna Zafar and Menahil Fazal and Ravi Kumar Pandey and Rida Khan and Muhammad Hassan and Ashish Kumar and Abdullah Naeem and Usman Zia and Yahye Ahmed Nor},
journal = {Medicine},
year = {2026},
month = nov,
doi = {10.1097/md.0000000000051448},
url = {https://doi.org/10.1097/md.0000000000051448},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - National trends and demographic disparities in mortality involving co-listed chronic obstructive pulmonary disease and substance use disorders among U.S. adults aged ≥65 years: A population-based serial cross-sectional CDC WONDER analysis, 1999 to 2020
AU - Mirza Ammar Arshad
AU - Urwah Noor
AU - Rida Fatima
AU - Fatima Maqsood
AU - Hassan Faraz Chaudhry
AU - Muhammad Shumas
AU - Amna Zafar
AU - Menahil Fazal
AU - Ravi Kumar Pandey
AU - Rida Khan
AU - Muhammad Hassan
AU - Ashish Kumar
AU - Abdullah Naeem
AU - Usman Zia
AU - Yahye Ahmed Nor
PY - 2026
DA - 2026/11/06
JO - Medicine
DO - 10.1097/md.0000000000051448
UR - https://doi.org/10.1097/md.0000000000051448
AB - Chronic obstructive pulmonary disease (COPD) and substance use disorders (SUDs) frequently coexist, yet national mortality patterns involving both conditions among older adults remain incompletely characterized. We evaluated temporal, demographic, geographic, and substance-specific patterns in U.S. death records co-listing COPD and SUDs among adults aged ≥65 years. We conducted a descriptive serial cross-sectional analysis of Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research multiple cause of death data from 1999 to 2020. Eligible records included deaths among adults aged ≥65 years in which COPD (International Classification of Diseases, 10th revision J41–J44) and SUDs (F10–F19) were both recorded in the Multiple Cause of Death fields. Age-adjusted mortality rates (AAMRs) were calculated overall and by sex, race/ethnicity, census region, urbanization, and state; age-group analyses used age-specific crude mortality rates. Joinpoint regression estimated annual percent changes and average annual percent changes. Secondary analyses examined individual F10 to F19 categories, with a sensitivity analysis excluding tobacco/nicotine-related disorders (F17). Among 1,524,216 qualifying deaths, the overall AAMR increased from 25.5/100,000 in 1999 to 213.2 in 2020, peaking at 219.0 in 2017. Males had higher pooled AAMRs than females (216.98 vs 132.54). The highest pooled racial/ethnic AAMR occurred among non-Hispanic American Indian or Alaska Native adults (191.99), followed closely by non-Hispanic White adults (188.68). The Midwest had the highest regional AAMR, while nonmetropolitan counties had higher AAMRs than metropolitan counties (232.82 vs 152.03). Tobacco/nicotine-related disorders accounted for the predominant substance-specific burden. Excluding F17 yielded an average annual percent change of 2.19% (95% confidence interval, 1.37–3.02). In the overall F10 to F19 analysis, mortality involving co-listed COPD and SUDs increased markedly during the earlier study period before stabilizing, whereas temporal trajectories differed across individual substance categories. Substantial demographic, geographic, and substance-specific heterogeneity was observed. Findings are descriptive and should not be interpreted causally.
SN - 0025-7974
SN - 1536-5964
ER -